Status:
UNKNOWN
Protocol-Specified Modification of Immunosuppression Directed to Protocol Biopsy in Kidney Transplantation
Lead Sponsor:
Chulalongkorn University
Conditions:
Surveillance Protocol Biopsy
Eligibility:
All Genders
17-70 years
Phase:
NA
Brief Summary
The risk-benefit of surveillance-protocol biopsy (SPBx) in kidney transplantation remains unclear. The study aims to compare outcomes of recipients with SPBx approach to recipients with standard appro...
Detailed Description
The present randomized-controlled trial in kidney transplant patients aims to compare the outcomes and complications between who underwent immunosuppessive drug modification under surveillance-protoco...
Eligibility Criteria
Inclusion
- All kidney transplant recipients underwent transplantation at Chulalongkorn University
Exclusion
- Pregnancy
- Recipients who cannot withhold aspirin, clopidogrel, warfarin, etc.
- Non-cooperated recipients
Key Trial Info
Start Date :
November 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2016
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT02294097
Start Date
November 1 2014
End Date
December 1 2016
Last Update
November 19 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Nephrology, Department of Medicine, Faculty of Medicine, Chulalongkorn University
Bangkok, Bangkok, Thailand, 10330